Cited by 1,090MicroRNA in disease regulationCancer-related molecular mechanisms researchCancer-related Molecular Pathways

MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)

Open access
Zhu, Shuomin, Si, Min-Liang, Wu, Hailong, Mo, Yin-Yuan·2007·Journal of Biological Chemistry

Abstract

MicroRNAs are small noncoding RNA molecules that control expression of target genes. Our previous studies show that mir-21 is overexpressed in tumor tissues compared with the matched normal tissues. Moreover, suppression of mir-21 by antisense oligonucleotides inhibits tumor cell growth both in vitro and in vivo. However, it remains largely unclear as to how mir-21 affects tumor growth, because our understanding of mir-21 targets is limited. In this study, we performed two-dimensional differentiation in-gel electrophoresis of tumors treated with anti-mir-21 and identified the tumor suppressor tropomyosin 1 (TPM1) as a potential mir-21 target. In agreement with this, there is a putative mir-21 binding site at the 3'-untranslated region (3'-UTR) of TPM1 variants V1 and V5. Thus, we cloned the 3'-UTR of TPM1 into a luciferase reporter and found that although mir-21 down-regulated the luciferase activity, anti-mir-21 up-regulated it. Moreover, deletion of the mir-21 binding site abolished the effect of mir-21 on the luciferase activity, suggesting that this mir-21 binding site is critical. Western blot with the cloned TPM1-V1 plus the 3'-UTR indicated that TPM1 protein level was also regulated by mir-21, whereas real-time quantitative reverse transcription-PCR revealed no difference at the mRNA level, suggesting translational regulation. Finally, overexpression of TPM1 in breast cancer MCF-7 cells suppressed anchorage-independent growth. Thus, down-regulation of TPM1 by mir-21 may explain, at least in part, why suppression of mir-21 can inhibit tumor growth, further supporting the notion that mir-21 functions as an oncogene.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m611393200

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., Rassenti, L., Kipps, T., Negrini, M., Bullrich, F., and Croce, C. M. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 15524 -15529
  2. Si, M. L., Zhu, S., Wu, H., Lu, Z., Wu, F., and Mo, Y. Y. (2006) Oncogene, in press
  3. Boyd, J., Risinger, J. I., Wiseman, R. W., Merrick, B. A., Selkirk, J. K., and Barrett, J. C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11534 -11538
  4. Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., Rassenti, L., Alder, H., Volinia, S., Liu, C. G., Kipps, T. J., Negrini, M., and Croce, C. M. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 13944 -13949
  5. Prasad, G. L., Fuldner, R. A., and Cooper, H. L. (1993) Proc. Natl. Acad. Sci.

Cited by

Sorted by citations

Authors
Zhu, S., Si, M.-L., Wu, H., & Mo, Y.-Y.
Affiliations
SIU Medicine (US)
Corresponding author
Mo, Yin-Yuan
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2007-05
Volume
282
Issue
19
Pages
14328-14336
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2008955962
Cited by
1,090
References
1
Citations by year
2026: 9 · 2025: 18 · 2024: 25 · 2023: 20 · 2022: 29 · 2021: 32 · 2020: 34 · 2019: 31 · 2018: 35 · 2017: 45 · 2016: 56 · 2015: 75 · 2014: 80 · 2013: 76 · 2012: 93
FWCI
38.68
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • National Institutes of Health
  • National Cancer Institute (R01CA102630, CA 102630)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
miR-21, TPM1, microRNA target regulation, 3' untranslated region, translational regulation, tumor suppressor, oncogenes, breast cancer, MCF-7 cells, anchorage-independent growth, antisense oligonucleotides
MeSH terms
Animals, Breast Neoplasms, Cell Adhesion, Female, Humans, Luciferases, Mice, Nude, RNA Processing, Post-Transcriptional, RNA, Messenger, Tropomyosin, Tumor Stem Cell Assay, Gene Expression Regulation, Neoplastic, Oligonucleotides, Antisense, 3' Untranslated Regions, MicroRNAs, Cell Line, Tumor, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review